In conclusion, short‐term AOAA treatment during the peak inflammatory phase of the immune response significantly improves cardiac function in mouse with MI, and its effect may be achieved by balancing the macrophage polarization, especially through modulating macrophage metabolism and inhibiting NLRP3‐Caspase1/IL‐1β pathway. The gene discussed is NLRP3; the disease is myocardial infarction.